Seeking Alpha
09 Oct 2026, 21:11 UTC · 1h ago
Humana Surges On 2027 CMS Ratings, Technical Breakout, Shares Fairly Priced
Impact · against what's priced in
The news is neutral for Humana as the market has already absorbed the Medicare Advantage rate increases and the company's recovery trajectory. While the 4-star rating is a positive fundamental, it does not yet bridge the gap to the top-quartile recovery the market currently refuses to price in.
- HUM+0.00
Already priced in
- The price assumes
The 2.48% CMS payment increase for 2027
The regain of a 4-star rating and the resulting 5% benchmark rate advantage for 2027 align with the positive CMS payment catalysts the price already assumes.
What HUM's price assumes · Sep 1
Top 2 movers · tap to explore
